JPS5835968B2 - サイクロデキストリン包接化合物の製造法 - Google Patents
サイクロデキストリン包接化合物の製造法Info
- Publication number
- JPS5835968B2 JPS5835968B2 JP49021374A JP2137474A JPS5835968B2 JP S5835968 B2 JPS5835968 B2 JP S5835968B2 JP 49021374 A JP49021374 A JP 49021374A JP 2137474 A JP2137474 A JP 2137474A JP S5835968 B2 JPS5835968 B2 JP S5835968B2
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- freeze
- drug
- water
- clathrate compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920000858 Cyclodextrin Polymers 0.000 title claims description 44
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title claims description 22
- 150000001875 compounds Chemical class 0.000 title claims description 18
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 239000003814 drug Substances 0.000 claims description 34
- 229940079593 drug Drugs 0.000 claims description 26
- 238000004108 freeze drying Methods 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000001116 FEMA 4028 Substances 0.000 description 21
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 21
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 21
- 229960004853 betadex Drugs 0.000 description 21
- 238000000034 method Methods 0.000 description 18
- LPEPZBJOKDYZAD-UHFFFAOYSA-N flufenamic acid Chemical compound OC(=O)C1=CC=CC=C1NC1=CC=CC(C(F)(F)F)=C1 LPEPZBJOKDYZAD-UHFFFAOYSA-N 0.000 description 14
- 229960004369 flufenamic acid Drugs 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000010586 diagram Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- OEERIBPGRSLGEK-UHFFFAOYSA-N carbon dioxide;methanol Chemical compound OC.O=C=O OEERIBPGRSLGEK-UHFFFAOYSA-N 0.000 description 2
- 238000000975 co-precipitation Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000004455 differential thermal analysis Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 238000002076 thermal analysis method Methods 0.000 description 2
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 1
- 235000021538 Chard Nutrition 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- NHUHCSRWZMLRLA-UHFFFAOYSA-N Sulfisoxazole Chemical compound CC1=NOC(NS(=O)(=O)C=2C=CC(N)=CC=2)=C1C NHUHCSRWZMLRLA-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229960000212 aminophenazone Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- WOIIIUDZSOLAIW-NSHDSACASA-N azapropazone Chemical compound C1=C(C)C=C2N3C(=O)[C@H](CC=C)C(=O)N3C(N(C)C)=NC2=C1 WOIIIUDZSOLAIW-NSHDSACASA-N 0.000 description 1
- 229960001671 azapropazone Drugs 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960004782 chlordiazepoxide Drugs 0.000 description 1
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PFAXACNYGZVKMX-UHFFFAOYSA-N fenethazine Chemical compound C1=CC=C2N(CCN(C)C)C3=CC=CC=C3SC2=C1 PFAXACNYGZVKMX-UHFFFAOYSA-N 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960000654 sulfafurazole Drugs 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JNMRHUJNCSQMMB-UHFFFAOYSA-N sulfathiazole Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CS1 JNMRHUJNCSQMMB-UHFFFAOYSA-N 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 239000003204 tranquilizing agent Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- ZEWQUBUPAILYHI-UHFFFAOYSA-N trifluoperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZEWQUBUPAILYHI-UHFFFAOYSA-N 0.000 description 1
- 229960002324 trifluoperazine Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Indole Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49021374A JPS5835968B2 (ja) | 1974-02-25 | 1974-02-25 | サイクロデキストリン包接化合物の製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49021374A JPS5835968B2 (ja) | 1974-02-25 | 1974-02-25 | サイクロデキストリン包接化合物の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS50116617A JPS50116617A (enExample) | 1975-09-12 |
| JPS5835968B2 true JPS5835968B2 (ja) | 1983-08-05 |
Family
ID=12053308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP49021374A Expired JPS5835968B2 (ja) | 1974-02-25 | 1974-02-25 | サイクロデキストリン包接化合物の製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5835968B2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988003023A1 (fr) * | 1986-10-31 | 1988-05-05 | Mitsubishi Chemical Industries Limited | Composition de medicament contre les maladies du foie et procede de preparation |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5646837A (en) * | 1979-09-27 | 1981-04-28 | Kowa Yakuhin Kogyo Kk | Preparation of ibuprofen clathrate compound |
| HU181703B (en) * | 1980-05-09 | 1983-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents |
| JPS57142962A (en) * | 1981-02-28 | 1982-09-03 | Santen Pharmaceut Co Ltd | Cyclodextrin clathrate compound of sulfur-containing compound |
| JPS5984821A (ja) * | 1982-11-04 | 1984-05-16 | Teikoku Chem Ind Corp Ltd | 徐溶化組成物 |
| JPS59106424A (ja) * | 1982-12-09 | 1984-06-20 | Kyorin Pharmaceut Co Ltd | 易吸収性キノリンカルボン酸誘導体組成物およびその製剤 |
| JPS59130900A (ja) * | 1983-01-17 | 1984-07-27 | Zeria Shinyaku Kogyo Kk | フルオロメトロン水性製剤の製造法 |
| JPS59137499A (ja) * | 1983-01-28 | 1984-08-07 | Nippon Shokuhin Kako Kk | ルチンとシクロデキストリンとの包接化合物 |
| US4616008A (en) * | 1984-05-02 | 1986-10-07 | Takeda Chemical Industries, Ltd. | Antibacterial solid composition for oral administration |
| JPH0660101B2 (ja) * | 1984-11-27 | 1994-08-10 | 参天製薬株式会社 | クロベタゾン−１７−ブチレ−トの水性製剤 |
| JPS6272688A (ja) * | 1985-09-25 | 1987-04-03 | Ss Pharmaceut Co Ltd | 鎮咳去痰組成物 |
| JPH0625123B2 (ja) * | 1985-12-12 | 1994-04-06 | 大塚製薬株式会社 | カルボスチリル誘導体−シクロデキストリン包接化合物 |
| JP3176716B2 (ja) * | 1991-06-21 | 2001-06-18 | 武田薬品工業株式会社 | 溶解性が向上した難水溶性薬物組成物 |
| US7704975B2 (en) | 2000-12-19 | 2010-04-27 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
| US7141555B2 (en) * | 2000-12-19 | 2006-11-28 | Cephalon, Inc. | Modafinil compound and cyclodextrin mixtures |
| CZ300120B6 (cs) * | 2006-06-20 | 2009-02-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| EP2238973A1 (en) | 2009-04-07 | 2010-10-13 | Cephalon France | Lyophilized preparations of proteasome inhibitors |
| MX2023013984A (es) * | 2021-05-26 | 2023-12-12 | Daewoong Pharmaceutical Co Ltd | Nueva formulacion para inyeccion que comprende 1-(5-(2,4-difluorofenil)-1-((3-fluorofenil)sulfonil)-4-metoxi-1h- pirrol-3-il)-n-metilmetanamina. |
-
1974
- 1974-02-25 JP JP49021374A patent/JPS5835968B2/ja not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988003023A1 (fr) * | 1986-10-31 | 1988-05-05 | Mitsubishi Chemical Industries Limited | Composition de medicament contre les maladies du foie et procede de preparation |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS50116617A (enExample) | 1975-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5835968B2 (ja) | サイクロデキストリン包接化合物の製造法 | |
| US4927636A (en) | Association complex comprising pullulan and polyethylene glycol, and preparation and uses of the same | |
| JPH0819004B2 (ja) | 徐放性医薬製剤 | |
| JP5566408B2 (ja) | ドライシロップ剤 | |
| WO2001041757A1 (en) | Cyclodextrin-containing pharmaceutical composition | |
| EP0491897A1 (en) | Liquid oral pharmaceutical compositions having anti-inflammatory activity | |
| EP0633787B1 (en) | Use of ibuprofen-beta-cyclodextrin complex for oral consumption | |
| PT756493E (pt) | Complexos de inclusao com componentes multiplos de elevada solubilidade que contem um medicamento acido uma ciclodextrina e uma base | |
| JPS63183546A (ja) | イブプロキサムとβ‐シクロデキストリンとの包接複合体、その製造法及びそれを含有する医薬製剤 | |
| JPH10500982A (ja) | 医薬組成物 | |
| JPS63135402A (ja) | シクロデキストリン組成物 | |
| US7037928B2 (en) | Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides | |
| JP2582497B2 (ja) | Ｎ―エトキシカルボニル―３―モルホリノ―シドノンイミン又はその塩の、シクロデキストリン誘導体を用いて形成される包接錯体、それらの製造法及び該錯体を含有する医薬組成物 | |
| JPH035438A (ja) | フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤 | |
| EP2902019B1 (en) | Compositions comprising inclusion complexes of cyclodextrins with spermidine for use in oral care | |
| CN115969729A (zh) | 乙酰基二肽-1鲸蜡酯的包合物及其制备方法 | |
| CN108210937A (zh) | 吡咯烷基二氨基嘧啶氧化物β-环糊精基包合物及其制备方法 | |
| JP2779424B2 (ja) | α−トコフエロールビタミンＡ酸エステル−シクロデキストリン複合体 | |
| US5712260A (en) | Estramustine formulations with improved pharmaceutical properties | |
| Onyeji | Cyclodextrin complexes: utility in improving drug bioavailability and other applications | |
| JPS632929A (ja) | アセチルサリチル酸製剤 | |
| JPH09502190A (ja) | ベータ−シクロデキストリンとフルルビプロフェン、ケトプロフェンおよびナプロキセンとの封入複合物 | |
| JPH02300140A (ja) | 薬物のシクロデキストリン包接体及びその製造法 | |
| Panda et al. | Cyclodextrin as carrier for drug delivery systems | |
| JP4582960B2 (ja) | 浴用組成物 |